HLA-G and melanoma: This was demonstrated by the low percentage of Tra-1-85-positive HLA-G-depleted lung (0.00 to 0.15%) and melanoma BMICs (0.01 to 0.03%) compared to the high percentage of Tra-1-85-positive control lung (0.03 to 1.27%) and melanoma (0.03 to 8.98%) BMICs captured from the processed brains of the respective mice groups (Fig. 2D; n = 6, P = 0.02, and n = 4; P = 0.03).